ModernVivo

ModernVivo

Software Development

Helping research pharmacologists write better animal model protocols faster than the status quo.

About us

We are developing a software platform that utilizes machine learning and natural language processing technologies to improve clinical success and development times of drug discovery projects by automating the animal model (in-vivo) protocol design process.

Industry
Software Development
Company size
2-10 employees
Type
Privately Held
Founded
2023
Specialties
Research, Animal Model, In-vivo, Machine Learning, Artificial Intelligence, Natural Language Processing, Large Language Models, Statistics, Literature Reviews, Preclinical, Studies, and Pharmacology

Employees at ModernVivo

Updates

Similar pages

Funding

ModernVivo 7 total rounds

Last Round

Convertible note

US$ 100.0K

See more info on crunchbase